• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multidrug-resistant bacteroides fragilis--Seattle, Washington, 2013.艰难梭菌耐药菌株——华盛顿州西雅图,2013 年。
MMWR Morb Mortal Wkly Rep. 2013 Aug 30;62(34):694-6.
2
Multidrug-resistant Bacteroides fragilis group on the rise in Europe?欧洲艰难梭菌耐药群呈上升趋势?
J Med Microbiol. 2012 Dec;61(Pt 12):1784-1788. doi: 10.1099/jmm.0.049825-0. Epub 2012 Sep 6.
3
First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain.匈牙利首例由耐多药脆弱拟杆菌菌株引起的感染病例。
Anaerobe. 2015 Feb;31:55-8. doi: 10.1016/j.anaerobe.2014.09.019. Epub 2014 Oct 5.
4
Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.两例由耐多药脆弱拟杆菌群菌株引起的感染病例。
J Clin Microbiol. 2006 Sep;44(9):3465-7. doi: 10.1128/JCM.00316-06.
5
The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.替加环素对脆弱拟杆菌属的体外活性未得到充分重视,包括对甲硝唑和碳青霉烯类耐药的菌株。
Anaerobe. 2017 Feb;43:1-3. doi: 10.1016/j.anaerobe.2016.09.008. Epub 2016 Oct 3.
6
Fatal sepsis caused by multidrug-resistant Bacteroides fragilis, harboring a cfiA gene and an upstream insertion sequence element, in Japan.在日本,携带cfiA基因和上游插入序列元件的耐多药脆弱拟杆菌引起的致命性败血症。
Anaerobe. 2017 Apr;44:36-39. doi: 10.1016/j.anaerobe.2017.01.010. Epub 2017 Jan 17.
7
First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.首个关于脆弱拟杆菌群抗生素敏感性的全国性调查:阿根廷出现碳青霉烯类耐药。
Antimicrob Agents Chemother. 2012 Mar;56(3):1309-14. doi: 10.1128/AAC.05622-11. Epub 2012 Jan 9.
8
Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.从华盛顿州一名患者体内分离出携带nimA硝基还原酶基因的耐甲硝唑脆弱拟杆菌。
J Clin Microbiol. 2004 Sep;42(9):4127-9. doi: 10.1128/JCM.42.9.4127-4129.2004.
9
Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.脆弱拟杆菌碳青霉烯类耐药:分子机制综述。
Anaerobe. 2022 Aug;76:102606. doi: 10.1016/j.anaerobe.2022.102606. Epub 2022 Jun 20.
10
Mechanisms of Bacteroides fragilis resistance to metronidazole.脆弱拟杆菌对甲硝唑耐药的机制。
Infect Genet Evol. 2018 Oct;64:156-163. doi: 10.1016/j.meegid.2018.06.020. Epub 2018 Jun 21.

引用本文的文献

1
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.结直肠癌患者中具核梭杆菌和脆弱拟杆菌的全球患病率:病例报告/病例系列概述及患病率研究的荟萃分析
BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x.
2
Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against .针对. 的噬菌体 GEC_vB_Bfr_UZM3 的特性分析
Viruses. 2023 Apr 25;15(5):1042. doi: 10.3390/v15051042.
3
CRISPR-Cas Systems in , an Important Pathobiont in the Human Gut Microbiome.人类肠道微生物群中的重要病理共生菌——[具体名称未给出]中的CRISPR-Cas系统 。 (你提供的原文似乎不完整,“in”后面缺少具体内容)
Front Microbiol. 2017 Nov 23;8:2234. doi: 10.3389/fmicb.2017.02234. eCollection 2017.
4
A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.一种用于从临床标本中分离脆弱拟杆菌的新型选择性培养基。
J Clin Microbiol. 2017 Feb;55(2):384-390. doi: 10.1128/JCM.01988-16. Epub 2016 Nov 16.
5
Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties.战斗伤员伤口分离出的专性厌氧菌的流行病学及抗菌药敏情况
Diagn Microbiol Infect Dis. 2016 Feb;84(2):144-50. doi: 10.1016/j.diagmicrobio.2015.10.010. Epub 2015 Oct 23.
6
Characterization of a multidrug-resistant, novel Bacteroides genomospecies.一种耐多药新型拟杆菌基因组种的特性分析
Emerg Infect Dis. 2015 Jan;21(1):95-8. doi: 10.3201/eid2101.140662.
7
Deficiency of the ferrous iron transporter FeoAB is linked with metronidazole resistance in Bacteroides fragilis.亚铁转运蛋白FeoAB的缺陷与脆弱拟杆菌对甲硝唑的耐药性有关。
J Antimicrob Chemother. 2014 Oct;69(10):2634-43. doi: 10.1093/jac/dku219. Epub 2014 Jul 14.

本文引用的文献

1
Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey.在一项全欧抗生素耐药性调查中报告的拟杆菌属菌株对碳青霉烯类和甲硝唑耐药机制的分子分析。
Int J Antimicrob Agents. 2013 Feb;41(2):122-5. doi: 10.1016/j.ijantimicag.2012.10.001. Epub 2012 Nov 14.
2
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.耐碳青霉烯类肠杆菌科细菌:流行病学与预防。
Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202.
3
Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.从血液和阿富汗简易爆炸装置(IED)造成的严重腿部创伤中分离出的多药耐药脆弱拟杆菌。
Anaerobe. 2011 Aug;17(4):152-5. doi: 10.1016/j.anaerobe.2011.02.007. Epub 2011 Mar 3.
4
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.欧洲脆弱拟杆菌群分离株的抗菌药敏性:20 年的经验。
Clin Microbiol Infect. 2011 Mar;17(3):371-9. doi: 10.1111/j.1469-0691.2010.03256.x.
5
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).从厌氧菌调查中吸取的教训:历史透视和对最新数据(2005-2007 年)的回顾。
Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S26-33. doi: 10.1086/647940.
6
Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.耐多药脆弱拟杆菌所致厌氧败血症:利奈唑胺治疗的微生物学治愈及临床反应
Clin Infect Dis. 2005 Apr 1;40(7):e67-8. doi: 10.1086/428623. Epub 2005 Mar 2.
7
Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.从华盛顿州一名患者体内分离出携带nimA硝基还原酶基因的耐甲硝唑脆弱拟杆菌。
J Clin Microbiol. 2004 Sep;42(9):4127-9. doi: 10.1128/JCM.42.9.4127-4129.2004.
8
Emergence of metronidazole-resistant Bacteroides fragilis, India.印度出现对甲硝唑耐药的脆弱拟杆菌。
Emerg Infect Dis. 2001 May-Jun;7(3):485-6. doi: 10.3201/eid0703.010332.

艰难梭菌耐药菌株——华盛顿州西雅图,2013 年。

Multidrug-resistant bacteroides fragilis--Seattle, Washington, 2013.

出版信息

MMWR Morb Mortal Wkly Rep. 2013 Aug 30;62(34):694-6.

PMID:23985497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4604994/
Abstract

The Bacteroides fragilis group consists of species of obligate anaerobic bacteria that inhabit the human gut. They are among the leading pathogens isolated in the setting of intra-abdominal infections. B. fragilis strains, especially in the United States, are virtually always susceptible to metronidazole, carbapenems, and beta-lactam antibiotics. Although isolated cases of resistance to single agents have been reported, multidrug-resistant (MDR) B. fragilis strains are exceptionally rare. In May 2013, an MDR B. fragilis strain was isolated from the bloodstream and intra-abdominal abscesses of a patient who had recently received health care in India. This is only the second published case of MDR B. fragilis in the United States. This report summarizes the case and highlights the need for awareness of multidrug-resistant organisms (MDROs) in returning travelers who have received inpatient medical care outside the United States, both for timely implementation of proper infection control measures and to ensure administration of appropriate antimicrobials.

摘要

脆弱拟杆菌群由专性厌氧菌组成,栖息于人类肠道。它们是腹腔内感染中主要分离出的病原体之一。脆弱拟杆菌株,尤其是在美国,几乎对甲硝唑、碳青霉烯类和β-内酰胺类抗生素均敏感。虽然已报道有单一药物耐药的孤立病例,但多药耐药(MDR)脆弱拟杆菌株极为罕见。2013 年 5 月,从一位刚在印度接受过医疗保健的患者的血流和腹腔脓肿中分离出一株 MDR 脆弱拟杆菌。这是美国发表的第二例 MDR 脆弱拟杆菌感染。本报告总结了该病例,并强调了对从美国境外住院接受过医疗护理的归国旅行者中出现的多重耐药菌(MDRO)的认识,这对于及时实施适当的感染控制措施并确保使用适当的抗菌药物至关重要。